150 related articles for article (PubMed ID: 38132178)
21. Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
Huang Y; Zhou S; He C; Deng J; Tao T; Su Q; Darko KO; Peng M; Yang X
Cancer Commun (Lond); 2018 Jul; 38(1):50. PubMed ID: 30053908
[TBL] [Abstract][Full Text] [Related]
22. Addition of 2-deoxyglucose enhances growth inhibition but reverses acidification in colon cancer cells treated with phenformin.
Lea MA; Chacko J; Bolikal S; Hong JY; Chung R; Ortega A; desbordes C
Anticancer Res; 2011 Feb; 31(2):421-6. PubMed ID: 21378320
[TBL] [Abstract][Full Text] [Related]
23. Phenformin inhibits cell proliferation and induces cell apoptosis and autophagy in cholangiocarcinoma.
Hu S; Ouyang Q; Cheng Q; Wang J; Feng F; Qiao L; Gan W; Shi Y; Wu D; Jiang X
Mol Med Rep; 2018 Apr; 17(4):6028-6032. PubMed ID: 29436644
[TBL] [Abstract][Full Text] [Related]
24. Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.
Lee J; Lee I; Han B; Park JO; Jang J; Park C; Kang WK
J Natl Cancer Inst; 2011 Apr; 103(8):674-88. PubMed ID: 21398618
[TBL] [Abstract][Full Text] [Related]
25. A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer.
Yalikong A; Li XQ; Zhou PH; Qi ZP; Li B; Cai SL; Zhong YS
Int J Nanomedicine; 2021; 16():2323-2335. PubMed ID: 33776436
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells.
Woollhead AM; Sivagnanasundaram J; Kalsi KK; Pucovsky V; Pellatt LJ; Scott JW; Mustard KJ; Hardie DG; Baines DL
Br J Pharmacol; 2007 Aug; 151(8):1204-15. PubMed ID: 17603555
[TBL] [Abstract][Full Text] [Related]
27. Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway.
Nakamura Y; Hattori N; Iida N; Yamashita S; Mori A; Kimura K; Yoshino T; Ushijima T
Cancer Lett; 2017 Aug; 402():100-109. PubMed ID: 28576751
[TBL] [Abstract][Full Text] [Related]
28. Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF
Wang K; Li Y; Song N; Che X; Hou K; Xu L; Bai M; Wang Q; Wang Y; Zhou Y; Cao M; Liu Y; Zhang J
J Cell Biochem; 2019 Apr; 120(4):5315-5325. PubMed ID: 30320916
[TBL] [Abstract][Full Text] [Related]
29. BRAF
Reischmann N; Andrieux G; Griffin R; Reinheckel T; Boerries M; Brummer T
Oncogene; 2020 Sep; 39(38):6053-6070. PubMed ID: 32792685
[TBL] [Abstract][Full Text] [Related]
30. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
31.
Tan J; Liu R; Zhu G; Umbricht CB; Xing M
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15846-15851. PubMed ID: 32561648
[TBL] [Abstract][Full Text] [Related]
32. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
[TBL] [Abstract][Full Text] [Related]
33. Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.
Wang SS; Hsiao R; Limpar MM; Lomahan S; Tran TA; Maloney NJ; Ikegaki N; Tang XX
Int J Mol Med; 2014 Jan; 33(1):35-42. PubMed ID: 24190252
[TBL] [Abstract][Full Text] [Related]
34. MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.
Bozzi F; Mogavero A; Varinelli L; Belfiore A; Manenti G; Caccia C; Volpi CC; Beznoussenko GV; Milione M; Leoni V; Gloghini A; Mironov AA; Leo E; Pilotti S; Pierotti MA; Bongarzone I; Gariboldi M
J Exp Clin Cancer Res; 2017 Jan; 36(1):16. PubMed ID: 28114961
[TBL] [Abstract][Full Text] [Related]
35. BRAF V600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells.
Sueda T; Sakai D; Kawamoto K; Konno M; Nishida N; Koseki J; Colvin H; Takahashi H; Haraguchi N; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Satoh T; Doki Y; Mori M; Ishii H
Sci Rep; 2016 Jan; 6():18949. PubMed ID: 26750638
[TBL] [Abstract][Full Text] [Related]
36. Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport.
Velez J; Pan R; Lee JT; Enciso L; Suarez M; Duque JE; Jaramillo D; Lopez C; Morales L; Bornmann W; Konopleva M; Krystal G; Andreeff M; Samudio I
Oncotarget; 2016 Aug; 7(32):51435-51449. PubMed ID: 27283492
[TBL] [Abstract][Full Text] [Related]
37. Acetylsalicylic Acid Governs the Effect of Sorafenib in
Hammerlindl H; Ravindran Menon D; Hammerlindl S; Emran AA; Torrano J; Sproesser K; Thakkar D; Xiao M; Atkinson VG; Gabrielli B; Haass NK; Herlyn M; Krepler C; Schaider H
Clin Cancer Res; 2018 Mar; 24(5):1090-1102. PubMed ID: 29196297
[No Abstract] [Full Text] [Related]
38. Metformin for Prevention and Treatment of Colon Cancer: A Reappraisal of Experimental and Clinical Data.
Anisimov VN
Curr Drug Targets; 2016; 17(4):439-46. PubMed ID: 25738299
[TBL] [Abstract][Full Text] [Related]
39. Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922.
Wang CY; Guo ST; Wang JY; Yan XG; Farrelly M; Zhang YY; Liu F; Yari H; La T; Lei FX; Jin L; Zhang XD; Jiang CC
Oncotarget; 2016 Aug; 7(31):49597-49610. PubMed ID: 27391062
[TBL] [Abstract][Full Text] [Related]
40. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]